DSigDB Home
Search Gene
Collections
Browse Gene Sets
Download
Help

Gene Set: D4 : CTD - Ciprofloxacin


Collection D4 : CTD
Chemical Name Ciprofloxacin ( From PubChem : CIPROFLOXACIN )
FDA NPC WHO Indian Australia China Traditional
Herbal
Clinical
Trail
ApprovedNotApprovedApprovedNotApprovedNotNot
Molecular
Weight
Hydrogen Bond
Donor Count
Hydrogen Bond
Acceptor Count
cLogP Lipinski Rule
331.342 g/mol 2 6 1.9771 True
Structure
InChI InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)
InChIKey MYSWGUAQZAJSOK-UHFFFAOYSA-N
Links

Gene (36 / 120)


⊖ Less

Source Type Unit Value Gene PMID Assay Other
CTDdecreases(uptake)ABCC4
D002939
CTDincreases(expression)ABCC4
D002939
CTDdecreases(reaction)ABCC4
D002939
CTDdecreases(reaction)BAX
D002939
CTDincreases(localization)BAX
D002939
CTDincreases(expression)BAX
D002939
CTDincreases(localization)BAX
D002939
CTDdecreases(reaction)BCL2
D002939
CTDincreases(localization)BCL2
D002939
CTDaffects(cotreatment)BCL2
D002939
CTDdecreases(expression)BCL2
D002939
CTDincreases(activity)CASP3
D002939
CTDincreases(activity)CASP3
D002939
CTDincreases(cleavage)CASP3
D002939
CTDincreases(activity)CASP8
D002939
CTDincreases(activity)CASP9
D002939
CTDdecreases(expression)CCNB1
D002939
CTDdecreases(expression)CCNE1
D002939
CTDdecreases(phosphorylation)CDK2
D002939
CTDdecreases(expression)CDKN1A
D002939
CTDdecreases(expression)CDKN1A
D002939
CTDaffects(cotreatment)CEBPD
D002939
CTDdecreases(reaction)CEBPD
D002939
CTDincreases(activity)CEBPD
D002939
CTDaffects(cotreatment)CXCL8
D002939
CTDaffects(reaction)CXCL8
D002939
CTDincreases(expression)CXCL8
D002939
CTDdecreases(reaction)CXCL8
D002939
CTDincreases(secretion)CXCL8
D002939
CTDaffects(cotreatment)CXCL8
D002939
CTDincreases(expression)CXCL8
D002939
CTDincreases(reaction)CXCL8
D002939
CTDdecreases(secretion)CXCL8
D002939
CTDaffects(metabolic processing)CYP1A2
D002939
CTDdecreases(reaction)CYP1A2
D002939
CTDdecreases(methylation)CYP1A2
D002939
CTDdecreases(reaction)CYP1A2
D002939
CTDdecreases(activity)CYP1A2
D002939
CTDdecreases(activity)CYP1A2
D002939
CTDincreases(abundance)CYP1A2
D002939
CTDdecreases(activity)CYP3A4
D002939
CTDincreases(response to substance)G6PD
D002939
CTDaffects(cotreatment)IFNG
D002939
CTDdecreases(reaction)IFNG
D002939
CTDincreases(abundance)IFNG
D002939
CTDdecreases(expression)IFNG
D002939
CTDdecreases(reaction)IL10
D002939
CTDincreases(secretion)IL10
D002939
CTDaffects(cotreatment)IL1A
D002939
CTDdecreases(reaction)IL1A
D002939
CTDincreases(abundance)IL1A
D002939
CTDaffects(cotreatment)IL1B
D002939
CTDaffects(reaction)IL1B
D002939
CTDincreases(expression)IL1B
D002939
CTDaffects(cotreatment)IL1B
D002939
CTDdecreases(reaction)IL1B
D002939
CTDincreases(activity)IL1B
D002939
CTDaffects(cotreatment)IL1B
D002939
CTDdecreases(reaction)IL1B
D002939
CTDincreases(expression)IL1B
D002939
CTDdecreases(reaction)IL1B
D002939
CTDincreases(expression)IL1B
D002939
CTDincreases(secretion)IL1B
D002939
CTDincreases(expression)IL1B
D002939
CTDincreases(reaction)IL1B
D002939
CTDincreases(expression)IL1B
D002939
CTDincreases(reaction)IL1B
D002939
CTDincreases(expression)IL1B
D002939
CTDincreases(reaction)IL1B
D002939
CTDincreases(reaction)IL1B
D002939
CTDincreases(secretion)IL1B
D002939
CTDdecreases(expression)IL4
D002939
CTDaffects(cotreatment)IL6
D002939
CTDdecreases(reaction)IL6
D002939
CTDincreases(expression)IL6
D002939
CTDincreases(expression)MMP1
D002939
CTDincreases(reaction)MMP1
D002939
CTDincreases(reaction)MMP1
D002939
CTDincreases(secretion)MMP1
D002939
CTDincreases(expression)MMP1
D002939
CTDdecreases(reaction)MMP13
D002939
CTDincreases(expression)MMP13
D002939
CTDincreases(secretion)MMP13
D002939
CTDdecreases(expression)MMP13
D002939
CTDincreases(expression)MMP3
D002939
CTDincreases(reaction)MMP3
D002939
CTDincreases(secretion)MMP3
D002939
CTDdecreases(response to substance)NOD2
D002939
CTDincreases(cleavage)PARP1
D002939
CTDdecreases(activity)PON1
D002939
CTDaffects(localization)SLC2A1
D002939
CTDdecreases(expression)SLC2A1
D002939
CTDincreases(expression)TGFB1
D002939
CTDaffects(cotreatment)TNF
D002939
CTDaffects(reaction)TNF
D002939
CTDincreases(expression)TNF
D002939
CTDaffects(cotreatment)TNF
D002939
CTDdecreases(reaction)TNF
D002939
CTDincreases(abundance)TNF
D002939
CTDaffects(cotreatment)TNF
D002939
CTDdecreases(reaction)TNF
D002939
CTDincreases(activity)TNF
D002939
CTDaffects(cotreatment)TNF
D002939
CTDdecreases(reaction)TNF
D002939
CTDincreases(expression)TNF
D002939
CTDdecreases(reaction)TNF
D002939
CTDincreases(secretion)TNF
D002939
CTDincreases(expression)TNF
D002939
CTDincreases(reaction)TNF
D002939
CTDaffects(cotreatment)TOP1
D002939
CTDdecreases(activity)TOP1
D002939
CTDaffects(binding)TOP2A
D002939
CTDdecreases(reaction)TOP2A
D002939
ChEMBLInhibition-CYP1A2
-Target : CHEMBL3356
ChEMBLInhibition-CYP2C19
-Target : CHEMBL3622
ChEMBLInhibition-CYP2C9
-Target : CHEMBL3397
ChEMBLInhibition-CYP2D6
-Target : CHEMBL289
ChEMBLInhibition-CYP3A4
-Target : CHEMBL340
ChEMBLInhibition-CYP3A4
-Target : CHEMBL340
ChEMBLPotencynM12589.300HSD17B10
-Target : CHEMBL4159
Download gene sets gmt, text, Detailed text
Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA

* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).